[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1970

Congenital Bullous Ichthyosiform ErythrodermaEpidermolytic Hyperkeratosis—Treatment With Methotrexate

Author Affiliations

San Francisco

From the Division of Dermatology, Department of Medicine, University of California School of Medicine, San Francisco.

Arch Dermatol. 1970;101(5):528-530. doi:10.1001/archderm.1970.04000050032005
Abstract

In contrast to recently reported successful methotrexate therapy of congenital bullous ichthyosiform erythroderma (CBIE), two cases failed to respond to the dosages of methotrexate normally used in psoriasis. Thiamiprine was also without effect. This was despite the demonstration of markedly increased epidermal turnover in these patients using tritiated thymidine autoradiography. We suspect the failure to respond is because the increased epidermal cell turnover in this disease is a secondary phenomenon involving mechanisms not responsive to antimetabolites.

×